Report from the Annual General Meeting of Klaria Pharma Holding AB (publ)
Klaria Pharma Holding AB held its Annual General Meeting 2026, adopting the financial statements for the 2025 fiscal year and discharging the board and CEO from liability. Shareholders re-elected Fredrik Hübinette, Scott Boyer, and Anders Jacobson as board members and Azets Revision & Rådgivning AB as the company's auditor.
Key figures
- Board remuneration sek
- 200000
- Share issuance authorization percent
- 20
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.